Skip to main content
. 2017 Mar 16;15(3):e04691. doi: 10.2903/j.efsa.2017.4691

Figure B.4.

Figure B.4

MLL‐rearranged acute lymphoblastic leukaemias activate BCL‐2 through H3K79 methylation and are sensitive to the BCL‐2‐specific antagonist ABT‐199 (Benito et al., 2015, CC‐BY)